633 filings
Page 27 of 32
10-Q/A
2012 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report (amended)
14 Feb 12
12:00am
10-Q
2012 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
13 Feb 12
12:00am
10-K/A
2011 FY
NBSE
NeuBase Therapeutics Inc
Annual report (amended)
10 Feb 12
12:00am
CORRESP
NBSE
NeuBase Therapeutics Inc
8 Feb 12
Correspondence with SEC
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
1 Feb 12
Letter from SEC
12:00am
10-K/A
2011 FY
NBSE
NeuBase Therapeutics Inc
Annual report (amended)
18 Jan 12
12:00am
10-K
2011 FY
NBSE
NeuBase Therapeutics Inc
Annual report
13 Jan 12
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
9 Jan 12
Regulation FD Disclosure
12:00am
NT 10-K
NBSE
NeuBase Therapeutics Inc
28 Dec 11
Notice of late annual filing
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
20 Dec 11
Ohr Pharmaceutical Announces $1,100,000 Private Placement led by Existing Investors
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
2 Nov 11
Entry into a Material Definitive Agreement
12:00am
10-Q
2011 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report
15 Aug 11
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
18 Jul 11
Ohr Pharmaceutical Announces Positive Animal Studies for Novel Squalamine Eye Drop for Wet-AMD
12:00am
8-K
NBSE
NeuBase Therapeutics Inc
24 Jun 11
Ohr Pharmaceutical Announces Clinical Squalamine Eye Drop Program for Wet-amd
12:00am
10-Q
2011 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report
12 May 11
12:00am
UPLOAD
NBSE
NeuBase Therapeutics Inc
22 Feb 11
Letter from SEC
12:00am
10-Q
2011 Q1
NBSE
NeuBase Therapeutics Inc
Quarterly report
14 Feb 11
12:00am
10-Q/A
2010 Q3
NBSE
NeuBase Therapeutics Inc
Quarterly report (amended)
24 Jan 11
12:00am
10-Q/A
2010 Q2
NBSE
NeuBase Therapeutics Inc
Quarterly report (amended)
24 Jan 11
12:00am
CORRESP
NBSE
NeuBase Therapeutics Inc
21 Jan 11
Correspondence with SEC
12:00am